Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 23, 2020

SELL
$55.65 - $79.83 $326,943 - $469,001
-5,875 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$64.7 - $85.39 $116,201 - $153,360
1,796 Added 44.03%
5,875 $428,000
Q2 2019

Jul 10, 2019

SELL
$67.77 - $82.2 $325,092 - $394,313
-4,797 Reduced 54.04%
4,079 $335,000
Q1 2019

May 10, 2019

BUY
$45.83 - $70.54 $406,787 - $626,113
8,876 New
8,876 $626,000
Q3 2018

Nov 08, 2018

SELL
$52.95 - $71.34 $215,612 - $290,496
-4,072 Closed
0 $0
Q2 2018

Jul 13, 2018

BUY
$56.38 - $68.08 $229,579 - $277,221
4,072 New
4,072 $272,000
Q4 2017

Feb 14, 2018

SELL
$53.3 - $74.56 $444,202 - $621,383
-8,334 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$43.46 - $52.49 $362,195 - $437,451
8,334
8,334 $437,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.06B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.